These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effect of topical 16,16-dimethyl prostaglandin E2 on aspirin-induced disruption of gastric permeability barrier in dogs.
    Author: Cheung LY.
    Journal: Prostaglandins; 1981; 21 Suppl():125-9. PubMed ID: 7302257.
    Abstract:
    This study was designed to evaluate whether stimulation of mucus and alkaline secretion by topical 16,16-dimethyl prostaglandin E2 (dmPGE2) would protect gastric mucosa against aspirin-induced disruption of permeability barrier to lumina acid. A chambered segment of canine fundic stomach with intact vascular supply was partitioned into two compartments. One was pretreated with topical dmPGE2 (25 micrograms/15 ml isotonic acid) and the other served as control. Topical dmPGE2 resulted in 1) mucus release as evidenced by gross and microscopic examinations, 2) luminal volume gain from 0.05 +/- 0.01 to 1.05 +/- 0.30 ml/15 min (p less than 0.01) and 3) an increase in Na+ efflux from 9 +/- 4 to 165 +/- 20 muEq/15 min (p less than 0.001). These effects of dmPGE2 did not protect the gastric mucosa against disruption of permeability barrier induced by 20 mM aspirin, which resulted in a similar amount of H+ back-diffusion in dmPGE2-treated mucosa (8 +/- 7 to 129 +/- 8 muEq/15 min, p less than 0.001) and in control mucosa (from 5 +/- 7 to 118 +/- 24 muEq/15 min, p less than 0.001). Also there was no significant difference in the degree of reduction in mucosal potential difference between dmPGE2-treated mucosa (from 60 +/- 4 to 34 +/- 2 -mV p less than 0.01) and control mucosa (from 58 +/- 4 to 36 +/- 3 -mV p less than 0.001).
    [Abstract] [Full Text] [Related] [New Search]